Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II).
暂无分享,去创建一个
L. Frati | C. Raimondi | E. Petrelli | P. Grassi | M. di Seri | M. S. Rosati | M. Girolami | G. Baciarello | S. Giovannoni | M. Basile | M. Rosati